Tekla Capital Management LLC Dr Reddys Laboratories LTD Transaction History

Tekla Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$36.05 - $42.76 $1.04 Million - $1.24 Million	-28,950 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$35.77 - $40.57 $270,063 - $306,303	-7,550 Reduced 20.68%	28,950 $1.17 Million
Q4 2018 Feb 13, 2019	BUY	$31.89 - $38.44 $1.16 Million - $1.4 Million	36,500 New	36,500 $1.38 Million

233

24M

14.6K

2.8K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.